Skip to content
GLP-1 Savers
Menu
Ranked #377 · Watch List

Oak review

Nationwide coverage and no subscription to cancel, at $200/mo for compounded semaglutide and $250 for tirzepatide — one flat rate at every dose. Its advertising is the problem: nine different "starting" prices, not one of which comes with a term or is what it charges.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $250/mo

$250/mo semaglutide · $300/mo tirzepatide (one flat rate at every dose), read the afternoon of 15 August; both were $50 lower that morning

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. Oak publishes nine different "starting" prices — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — and attaches a term or a billing cadence to none of them. NONE of the nine is what it charges: its order form quotes $200/mo for semaglutide and $250 for tirzepatide, one flat rate at every dose, on its first screen before any question is answered. The "$133 / $199" it headlines is the three-month prepay under code OAKSAVE200, billed upfront.

How much does Oak cost?

The price Oak publishes is $250/mo semaglutide · $300/mo tirzepatide (one flat rate at every dose), read the afternoon of 15 August; both were $50 lower that morning. Compounded semaglutide is listed at $250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $200/mo that morning. We flag this one to watch: confirm the ongoing rate with Oak before you count on it, because a low first month can step up afterward.

Semaglutide
$250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $200/mo that morning
Tirzepatide
$300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $250/mo that morning
Coverage
All 50 states
Brand-name
Compounded only

The Value Score card

Oak scored on our six published factors. See the methodology.

Lowest Real Price34/100
No Teaser-Rate Bait32/100
Both Molecules80/100
Nationwide Availability95/100
Easy Cancellation88/100
Reputation66/100

Why it's a deal

  • All 50 states, offered in Spanish as well as English, with free shipping
  • No membership or subscription fee — Oak sells packages rather than a recurring plan, so there is nothing to cancel
  • Both compounded molecules are offered, and Oak states that all doses are the same price, so titrating up would not raise the bill if that holds
  • Same-day approval, which is genuinely fast if speed is what you are optimizing for

Read the fine print

  • Its published price is not stable enough to compare on — its order form moved by $50 inside a single day: $200/mo semaglutide and $250 tirzepatide on the morning of 15 August 2026, $250 and $300 that afternoon on the same page with browser storage cleared, every brand line $100 higher and the discount strike-throughs gone
  • No usable price. Oak publishes nine conflicting "starting" figures across its own pages — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — and attaches a term or billing cadence to none of them, so none can be compared against anything in this ranking
  • The two cheapest figures are not monthly rates. $119 and $185 appear only beside a "$200 off" new-patient offer, and Oak's own wording for that offer is "$50 off your first month, $200 off 3-months" — a three-month package discount
  • Its own undiscounted floors contradict each other: $190/mo on the weight-loss page and $167/mo in the comparison table on its front page, on the same site, on the same day
  • Its advertising and its order form disagree: none of the nine "starting" figures it markets is the $200/$250 it actually charges, so comparing Oak on its advertised numbers compares it against a price it does not offer
  • "All doses are the same price" is Oak's claim and we could not confirm it — a reading of its checkout copy recorded each dose step costing roughly $50–$75 more, and resolving that would require submitting the intake
  • Same-day approval with no video call means very little clinical contact before a prescription
  • Injection only — no oral or sublingual route, and no brand-name lane

The bottom line

Best for: People who want all-50-state coverage without a recurring commitment and are willing to complete a long intake before finding out what they will be charged. Nationwide coverage and no subscription to cancel, at $200/mo for compounded semaglutide and $250 for tirzepatide — one flat rate at every dose. Its advertising is the problem: nine different "starting" prices, not one of which comes with a term or is what it charges.

Ranked #377 of 418 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Get this deal

Compare with other deals

The programs scoring closest to Oak, out of 417 others we track.

Shopping Oak against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Oak, and every program that undercuts or outscores it — starting with Lemonaid Health, the closest match on score — is ranked on the Oak alternatives ranking.

More programs we track (24)

387 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Oak's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Oak's site. Not medical advice; see our disclosure.

Where Oak ranks

See every program ranked by price →

← Back to all deals